Source: Orthoworld

Medline: Medline Debuts Synthetic Ligament Augmentation Implant

by Julie A. Vetalice on March 25, 2025 Medline is introducing the Medline UNITE Synthetic Ligament Augmentation implant for tendon and ligament repair. Constructed from an open-weave synthetic non-resorbable material, the implant features hydrophilic microfilaments to allow for wicking of biological fluids. The multifilament structure is designed for cellular recruitment to promote tissue ingrowth, leading to a load-sharing construct and repair. The device also features a broad, low-profile design to minimize soft tissue irritation. When used in conjunction with Medline's DEXLOCK Knotless Suture Anchors, this device provides a novel solution for repair of the ATFL and other tendons and ligaments. "Medline UNITE continues to expand its soft tissue fixation portfolio to provide foot and ankle surgeons with options to help improve patient outcomes," said Scott Goldstein, Vice President of Product Management for Medline UNITE. "This new offering is backed by more than 30 years of clinical history in sports medicine across the world, and Medline is excited to introduce this technology for foot and ankle indications in the U.S. market." Source: Medline Medline is introducing the Medline UNITE Synthetic Ligament Augmentation implant for tendon and ligament repair. Constructed from an open-weave synthetic non-resorbable material, the implant features hydrophilic microfilaments to allow for wicking of biological fluids. The multifilament structure is designed for cellular recruitment to promote tissue ingrowth, leading to a load-sharing construct and repair. The device also features a broad, low-profile design to minimize soft tissue irritation. When used in conjunction with Medline's DEXLOCK Knotless Suture Anchors, this device provides a novel solution for repair of the ATFL and other tendons and ligaments. "Medline UNITE continues to expand its soft tissue fixation portfolio to provide foot and ankle surgeons with options to help improve patient outcomes," said Scott Goldstein, Vice President of Product Management for Medline UNITE. "This new offering is backed by more than 30 years of clinical history in sports medicine across the world, and Medline is excited to introduce this technology for foot and ankle indications in the U.S. market." Source: Medline

Read full article »
Est. Annual Revenue
$10-50B
Est. Employees
10-50K
Jim Boyle's photo - CEO of Medline

CEO

Jim Boyle

CEO Approval Rating

76/100

Read more